A Study to Evaluate Efficacy and Safety of Denosumab for Prevention and Treatment of Osteoporosis in 1st Time Liver Transplant Recipients.

NCT04231682 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Grant support was withdrawn from Amgen Pharmaceuticals

Conditions

Osteoporosis

Interventions

DRUG: Denosumab Injection
DRUG: Placebos

Sponsor

Albert Einstein Healthcare Network

Collaborators

[object Object]